Niagen Bioscience, Inc.
Nasdaq · Healthcare · Medicinal Chemicals & Botanical Products · Los Angeles, CA
NAGE chart
What traders are saying about $NAGE
Latest postsNiagen Bioscience, Inc. news
- Analysts Are More Bearish On Niagen Bioscience, Inc. (NASDAQ:NAGE) Than They Used To Be
Simply Wall St ·
- Niagen Bioscience Announces Participation in Upcoming Investor Conferences
Yahoo Finance ·
- Niagen Bioscience (NASDAQ:NAGE) Stock Price Target Cut by Freedom Broker
MarketBeat ·
- Freedom Broker Has Lowered Expectations for Niagen Bioscience (NASDAQ:NAGE) Stock Price
MarketBeat ·
- Freedom Broker maintains Niagen Bioscience at Buy, lowers price target to $6 from $8.50
TradingView ·
- Niagen Bioscience (NASDAQ:NAGE) Stock Price Target Cut by Canaccord Genuity Group
MarketBeat ·
- Niagen Bioscience Inc (OCD1.HA) balance sheet
Yahoo Finance UK ·
- Niagen Bioscience Inc. R (OCD1.HA) Q4 FY2025 earnings call transcript
Yahoo Finance ·
- Niagen Bioscience Inc (OCD1.HA) recent insider transactions
Yahoo Finance UK ·
- Q3 EPS Estimate for Niagen Bioscience Lowered by Analyst
MarketBeat ·
- Niagen Bioscience Inc (OCD1.HA) Company Profile & Facts - Yahoo Finance
Yahoo! Finance Canada ·
- Niagen Bioscience Inc (OCD1.HA) Stock Forum & Discussion - Yahoo Finance
Yahoo! Finance Canada ·
Niagen Bioscience, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $129.4M | $99.6M | $83.6M | $72.0M |
| Net income | $17.4M | $8.6M | -$4.9M | -$16.5M |
| Diluted EPS | $0.20 | $0.11 | $-0.07 | $-0.24 |
| Total assets (year end) | $106.4M | $68.3M | $55.0M | $54.1M |
| Cash and equivalents (year end) | – | $44.5M | $27.2M | $20.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Niagen Bioscience, Inc.
- Ticker
- NAGE (Nasdaq)
- Industry
- Medicinal Chemicals & Botanical Products
- Headquarters
- Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
Frequently asked questions
What exchange is Niagen Bioscience, Inc. listed on?
Niagen Bioscience, Inc. trades on the Nasdaq under the ticker symbol NAGE.
What industry is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is classified by the SEC under "Medicinal Chemicals & Botanical Products", part of the Healthcare sector on StockTweeting.
Where is Niagen Bioscience, Inc. headquartered?
Niagen Bioscience, Inc.'s business address on file with the SEC is in Los Angeles, CA.
When does Niagen Bioscience, Inc.'s fiscal year end?
Niagen Bioscience, Inc.'s fiscal year ends on December 31.
How much revenue did Niagen Bioscience, Inc. report?
Niagen Bioscience, Inc. reported $129.4M in revenue for calendar year 2025, according to its SEC filings.